Nonpharmacologic Management of Behavioral Symptoms in Dementia

Overview

Journal JAMA

Publisher American Medical Association

Specialty General Medicine

Date 2012 Nov 22

PMID 23168825

Citations 156

Authors

Laura N Gitlin

Helen C Kales

Constantine G Lyketsos

Affiliations

Soon will be listed here.

Abstract

Behavioral symptoms such as repetitive speech, wandering, and sleep disturbances are a core clinical feature of Alzheimer disease and related dementias. If untreated, these behaviors can accelerate disease progression, worsen functional decline and quality of life, cause significant caregiver distress, and result in earlier nursing home placement. Systematic screening for behavioral symptoms in dementia is an important prevention strategy that facilitates early treatment of behavioral symptoms by identifying underlying causes and tailoring a treatment plan. First-line nonpharmacologic treatments are recommended because available pharmacologic treatments are only modestly effective, have notable risks, and do not effectively treat some of the behaviors that family members and caregivers find most distressing. Examples of nonpharmacologic treatments include provision of caregiver education and support, training in problem solving, and targeted therapy directed at the underlying causes for specific behaviors (eg, implementing nighttime routines to address sleep disturbances). Based on an actual case, we characterize common behavioral symptoms and describe a strategy for selecting evidence-based nonpharmacologic dementia treatments. Nonpharmacologic management of behavioral symptoms in dementia can significantly improve quality of life and patient-caregiver satisfaction.

Citing Articles

Challenges and Opportunities in Implementing a Multicomponent Dementia Caregiver Program in a Complex Healthcare System.

Warren C, Ashcraft L, Peeples A, Piazza K, Goodman O, Gitlin L Inquiry. 2025; 62:469580251322364.

PMID: 40070359 PMC: 11898023. DOI: 10.1177/00469580251322364.

Neuropsychiatric Symptoms and Psychotropic Medication Use Following SARS-Cov-2 Infection Among Elderly Residents in Long-Term Care Facilities.

Cruz-Santiago D, Meng X, Canac-Marquis M, Sengupta A, Brassard J, Pavey E Can Geriatr J. 2025; 28(1):67-72.

PMID: 40051588 PMC: 11882206. DOI: 10.5770/cgj.28.770.

Trends of the Dementia Burden in South Asia: An Analysis of 2021 Global Burden of Disease Study.

Chauhan S, Jena D, Gaidhane S, Dev N, Bushi G, Priya G Aging Med (Milton). 2025; 8(1):e70002.

PMID: 40017668 PMC: 11865018. DOI: 10.1002/agm2.70002.

"": Care Partner Evaluation Results from a Four-Part, In-Person, Dementia Community Education Program.

Rubio O, Husser E, Wright R, Berish D, Whitaker J, Boltz M Int J Environ Res Public Health. 2025; 22(2).

PMID: 40003520 PMC: 11855293. DOI: 10.3390/ijerph22020295.

Cost-Effectiveness of the Tailored Activity Programme for Person With Dementia-Caregiver Dyads: A Markov Model.

Gannon B, Vo V, Gitlin L, Bennett S Int J Geriatr Psychiatry. 2025; 40(2):e70049.

PMID: 39924472 PMC: 11807937. DOI: 10.1002/gps.70049.

References

Beeri M, Werner P, Davidson M, Noy S . The cost of behavioral and psychological symptoms of dementia (BPSD) in community dwelling Alzheimer's disease patients. Int J Geriatr Psychiatry. 2002; 17(5):403-8. DOI: 10.1002/gps.490. View

Lawlor B . Managing behavioural and psychological symptoms in dementia. Br J Psychiatry. 2002; 181:463-5. DOI: 10.1192/bjp.181.6.463. View

Teri L, Logsdon R, Peskind E, Raskind M, Weiner M, Tractenberg R . Treatment of agitation in AD: a randomized, placebo-controlled clinical trial. Neurology. 2000; 55(9):1271-8. DOI: 10.1212/wnl.55.9.1271. View

Gitlin L, Jacobs M, Vause Earland T . Translation of a dementia caregiver intervention for delivery in homecare as a reimbursable Medicare service: outcomes and lessons learned. Gerontologist. 2010; 50(6):847-54. PMC: 2982211. DOI: 10.1093/geront/gnq057. View

Spillman B, Long S . Does high caregiver stress predict nursing home entry?. Inquiry. 2009; 46(2):140-61. DOI: 10.5034/inquiryjrnl_46.02.140. View

Staekenborg S, Su T, van Straaten E, Lane R, Scheltens P, Barkhof F . Behavioural and psychological symptoms in vascular dementia; differences between small- and large-vessel disease. J Neurol Neurosurg Psychiatry. 2009; 81(5):547-51. DOI: 10.1136/jnnp.2009.187500. View

Aalten P, de Vugt M, Jaspers N, Jolles J, Verhey F . The course of neuropsychiatric symptoms in dementia. Part I: findings from the two-year longitudinal Maasbed study. Int J Geriatr Psychiatry. 2005; 20(6):523-30. DOI: 10.1002/gps.1316. View

Cohen-Mansfield J . Nonpharmacologic interventions for inappropriate behaviors in dementia: a review, summary, and critique. Am J Geriatr Psychiatry. 2001; 9(4):361-81. View

Gitlin L, Corcoran M, Winter L, Boyce A, Hauck W . A randomized, controlled trial of a home environmental intervention: effect on efficacy and upset in caregivers and on daily function of persons with dementia. Gerontologist. 2001; 41(1):4-14. DOI: 10.1093/geront/41.1.4. View

10.

Ballard C, Hanney M, Theodoulou M, Douglas S, McShane R, Kossakowski K . The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial. Lancet Neurol. 2009; 8(2):151-7. DOI: 10.1016/S1474-4422(08)70295-3. View

11.

Callahan C, Boustani M, Unverzagt F, Austrom M, Damush T, Perkins A . Effectiveness of collaborative care for older adults with Alzheimer disease in primary care: a randomized controlled trial. JAMA. 2006; 295(18):2148-57. DOI: 10.1001/jama.295.18.2148. View

12.

Karttunen K, Karppi P, Hiltunen A, Vanhanen M, Valimaki T, Martikainen J . Neuropsychiatric symptoms and quality of life in patients with very mild and mild Alzheimer's disease. Int J Geriatr Psychiatry. 2011; 26(5):473-82. DOI: 10.1002/gps.2550. View

13.

Brodaty H, Arasaratnam C . Meta-analysis of nonpharmacological interventions for neuropsychiatric symptoms of dementia. Am J Psychiatry. 2012; 169(9):946-53. DOI: 10.1176/appi.ajp.2012.11101529. View

14.

Aalten P, de Vugt M, Jaspers N, Jolles J, Verhey F . The course of neuropsychiatric symptoms in dementia. Part II: relationships among behavioural sub-syndromes and the influence of clinical variables. Int J Geriatr Psychiatry. 2005; 20(6):531-6. DOI: 10.1002/gps.1317. View

15.

. 2012 Alzheimer's disease facts and figures. Alzheimers Dement. 2012; 8(2):131-68. DOI: 10.1016/j.jalz.2012.02.001. View

16.

Reuben D, Levin J, Frank J, Hirsch S, McCreath H, Roth C . Closing the dementia care gap: Can referral to Alzheimer's Association chapters help?. Alzheimers Dement. 2009; 5(6):498-502. PMC: 3688281. DOI: 10.1016/j.jalz.2009.01.024. View

17.

Salzman C, Jeste D, Meyer R, Cohen-Mansfield J, Cummings J, Grossberg G . Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policy. J Clin Psychiatry. 2008; 69(6):889-98. PMC: 2674239. DOI: 10.4088/jcp.v69n0602. View

18.

Teri L, Gibbons L, McCurry S, Logsdon R, Buchner D, Barlow W . Exercise plus behavioral management in patients with Alzheimer disease: a randomized controlled trial. JAMA. 2003; 290(15):2015-22. DOI: 10.1001/jama.290.15.2015. View

19.

Marra C, Quaranta D, Zinno M, Misciagna S, Bizzarro A, Masullo C . Clusters of cognitive and behavioral disorders clearly distinguish primary progressive aphasia from frontal lobe dementia, and Alzheimer's disease. Dement Geriatr Cogn Disord. 2007; 24(5):317-26. DOI: 10.1159/000108115. View

20.

Okura T, Plassman B, Steffens D, Llewellyn D, Potter G, Langa K . Neuropsychiatric symptoms and the risk of institutionalization and death: the aging, demographics, and memory study. J Am Geriatr Soc. 2011; 59(3):473-81. PMC: 3088883. DOI: 10.1111/j.1532-5415.2011.03314.x. View